These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36225141)

  • 21. Using the LASSI-L to Detect Robust Interference Effects in Premanifest Huntington Disease.
    Sierra LA; Ullman CJ; Frank SA; Laganiere S
    Cogn Behav Neurol; 2023 Jun; 36(2):100-107. PubMed ID: 36728399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Addenbrooke's cognitive examination III: diagnostic utility for mild cognitive impairment and dementia and correlation with standardized neuropsychological tests.
    Matias-Guiu JA; Cortés-Martínez A; Valles-Salgado M; Rognoni T; Fernández-Matarrubia M; Moreno-Ramos T; Matías-Guiu J
    Int Psychogeriatr; 2017 Jan; 29(1):105-113. PubMed ID: 27682860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Homocysteine - A predictor for five year-mortality in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer's dementia.
    Futschek IE; Schernhammer E; Haslacher H; Stögmann E; Lehrner J
    Exp Gerontol; 2023 Feb; 172():112045. PubMed ID: 36509298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recovery from Proactive Semantic Interference in Mild Cognitive Impairment and Normal Aging: Relationship to Atrophy in Brain Regions Vulnerable to Alzheimer's Disease.
    Loewenstein DA; Curiel RE; Wright C; Sun X; Alperin N; Crocco E; Czaja SJ; Raffo A; Penate A; Melo J; Capp K; Gamez M; Duara R
    J Alzheimers Dis; 2017; 56(3):1119-1126. PubMed ID: 28106554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utilizing semantic intrusions to identify amyloid positivity in mild cognitive impairment.
    Loewenstein DA; Curiel RE; DeKosky S; Bauer RM; Rosselli M; Guinjoan SM; Adjouadi M; Peñate A; Barker WW; Goenaga S; Golde T; Greig-Custo MT; Hanson KS; Li C; Lizarraga G; Marsiske M; Duara R
    Neurology; 2018 Sep; 91(10):e976-e984. PubMed ID: 30076274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validity and Reliability of the New Chinese Version of the Frontal Assessment Battery-Phonemic.
    Li X; Shen M; Jin Y; Jia S; Zhou Z; Han Z; Zhang X; Tong X; Jiao J
    J Alzheimers Dis; 2021; 80(1):371-381. PubMed ID: 33554904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Test Your Memory for Mild Cognitive Impairment (TYM-MCI).
    Brown JM; Lansdall CJ; Wiggins J; Dawson KE; Hunter K; Rowe JB; Parker RA
    J Neurol Neurosurg Psychiatry; 2017 Dec; 88(12):1045-1051. PubMed ID: 28912299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel cognitive assessment paradigm to detect Pre-mild cognitive impairment (PreMCI) and the relationship to biological markers of Alzheimer's disease.
    Crocco EA; Loewenstein DA; Curiel RE; Alperin N; Czaja SJ; Harvey PD; Sun X; Lenchus J; Raffo A; Peñate A; Melo J; Sang L; Valdivia R; Cardenas K
    J Psychiatr Res; 2018 Jan; 96():33-38. PubMed ID: 28957712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Memory complaints in subjective cognitive impairment, amnestic mild cognitive impairment and mild Alzheimer's disease.
    Ryu SY; Lee SB; Kim TW; Lee TJ
    Acta Neurol Belg; 2016 Dec; 116(4):535-541. PubMed ID: 26861053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Awareness of memory deficits in subjective cognitive decline, mild cognitive impairment, Alzheimer's disease and Parkinson's disease.
    Lehrner J; Kogler S; Lamm C; Moser D; Klug S; Pusswald G; Dal-Bianco P; Pirker W; Auff E
    Int Psychogeriatr; 2015 Mar; 27(3):357-66. PubMed ID: 25382659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impairment of Episodic-Specific Autobiographical Memory in Individuals with Subjective Cognitive Decline and in Patients with Prodromal or Mild Alzheimer's Disease.
    Bruus AE; Waldemar G; Vogel A
    J Alzheimers Dis; 2021; 84(4):1485-1496. PubMed ID: 34690146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Free and Cued Selective Reminding Test is superior to the Wechsler Memory Scale in discriminating mild cognitive impairment from Alzheimer's disease.
    Lemos R; Cunha C; Marôco J; Afonso A; Simões MR; Santana I
    Geriatr Gerontol Int; 2015 Aug; 15(8):961-8. PubMed ID: 25243721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterogeneity of Amyloid Binding in Cognitively Impaired Patients Consecutively Recruited from a Memory Clinic: Evaluating the Utility of Quantitative 18F-Flutemetamol PET-CT in Discrimination of Mild Cognitive Impairment from Alzheimer's Disease and Other Dementias.
    Bao YW; Chau ACM; Chiu PK; Shea YF; Kwan JSK; Chan FHW; Mak HK
    J Alzheimers Dis; 2021; 79(2):819-832. PubMed ID: 33361593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of Depressive Symptoms on Conversion from Mild Cognitive Impairment Subtypes to Alzheimer's Disease: A Community-Based Longitudinal Study.
    Kida J; Nemoto K; Ikejima C; Bun S; Kakuma T; Mizukami K; Asada T
    J Alzheimers Dis; 2016; 51(2):405-15. PubMed ID: 26890740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validity of the Georgian Montreal Cognitive Assessment for the Screening of Mild Cognitive Impairment and Dementia.
    Janelidze M; Mikeladze N; Bochorishvili N; Dzagnidze A; Kapianidze M; Mikava N; Khatiashvili I; Kakhiani D; Mirvelashvili E; Shiukashvili N; Nadareishvili Z
    Am J Alzheimers Dis Other Demen; 2017 Feb; 32(1):36-40. PubMed ID: 27909150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Types of errors on a semantic interference task in mild cognitive impairment and dementia.
    Torres VL; Rosselli M; Loewenstein DA; Curiel RE; Vélez Uribe I; Lang M; Arruda F; Penate A; Vaillancourt DE; Greig MT; Barker WW; Bauer RM; Duara R
    Neuropsychology; 2019 Jul; 33(5):670-684. PubMed ID: 31070384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Self-Administered Gerocognitive Examination: longitudinal cohort testing for the early detection of dementia conversion.
    Scharre DW; Chang SI; Nagaraja HN; Wheeler NC; Kataki M
    Alzheimers Res Ther; 2021 Dec; 13(1):192. PubMed ID: 34872596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional impairment in elderly patients with mild cognitive impairment and mild Alzheimer disease.
    Brown PJ; Devanand DP; Liu X; Caccappolo E;
    Arch Gen Psychiatry; 2011 Jun; 68(6):617-26. PubMed ID: 21646578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A cognitive stress test for prodromal Alzheimer's disease: Multiethnic generalizability.
    Curiel Cid RE; Loewenstein DA; Rosselli M; Matias-Guiu JA; Piña D; Adjouadi M; Cabrerizo M; Bauer RM; Chan A; DeKosky ST; Golde T; Greig-Custo MT; Lizarraga G; Peñate A; Duara R
    Alzheimers Dement (Amst); 2019 Dec; 11():550-559. PubMed ID: 31417955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort.
    Caminiti SP; Ballarini T; Sala A; Cerami C; Presotto L; Santangelo R; Fallanca F; Vanoli EG; Gianolli L; Iannaccone S; Magnani G; Perani D;
    Neuroimage Clin; 2018; 18():167-177. PubMed ID: 29387532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.